Connection
Satish Garg to Glucagon-Like Peptide 1
This is a "connection" page, showing publications Satish Garg has written about Glucagon-Like Peptide 1.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.772 |
|
|
|
-
Garg SK, Moser EG, Bode BW, Klaff LJ, Hiatt WR, Beatson C, Snell-Bergeon JK. Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial. Endocr Pract. 2013 Jan-Feb; 19(1):19-28.
Score: 0.372
-
Garg SK. The role of basal insulin and glucagon-like peptide-1 agonists in the therapeutic management of type 2 diabetes--a comprehensive review. Diabetes Technol Ther. 2010 Jan; 12(1):11-24.
Score: 0.302
-
Garg SK, Michels AW, Shah VN. Use of non-insulin therapies for type 1 diabetes. Diabetes Technol Ther. 2013 Nov; 15(11):901-8.
Score: 0.098